Industry Verticals »

All Categories

Insights »

About TMR »

Cardiopulmonary Stress Testing Systems Market Insights, 2019-2027

Cardiopulmonary Stress Testing Systems Market (Product Type - Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT); End-user - Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global cardiopulmonary stress testing systems market for the historical period 2017, based year 2018, and forecast period 2019–2027, rising geriatric population and increase in prevalence of coronary artery diseases such as acute myocardial infarction & angina pectoris are projected to drive the global cardiopulmonary stress testing systems market during the forecast period
  • According to the report, the global cardiopulmonary stress testing systems market was valued at US$ 4.5 Bn in 2018 and is anticipated to expand at a CAGR of 5.9% from 2019 to 2027

Increase Prevalence of Coronary Artery Disease to Drive the Growth of Cardiopulmonary Stress Testing Systems: Key Drivers

  • According to the World Health Organization (WHO), Coronary artery diseases account for 64% of all deaths due to cardiovascular and are one of the leading causes of death. It is a major cause of loss of quality of life among men and women. The organization also stated that cardiovascular diseases accounted for 17.3 million deaths in 2008 and the number is expected to increase to 23.3 million by 2030. Additionally, low to middle income countries accounted for 80% of the deaths caused by cardiovascular diseases.
  • According to the Heart Disease and Stroke Statistics of the American Heart Association (AHA) updated in 2016, reported that nearly 15.5 million people ≥20 years of age had coronary heart diseases in the U.S. The report also stated that prevalence of coronary heart diseases had increased with age for both women and men.

Rise in Geriatric Population Boost Market Growth

  • Increase in the geriatric population is one of the key drivers of the market. As per the United Nations, by 2050, older persons are expected to account for more than 25% of the population in Europe and Northern America, 20% in Oceania, 17% in Asia, Latin America & the Caribbean, and 6% in Africa.
  • Japan is home to the world’s most aged population, with 33% of the population aged 60 years or above in 2015. The percentage is expected to reach 38% by 2050. In Italy, Germany, and Finland, 29%, 28%, and 27% of the population is aged 60 or above.
  • According to United Nations statistics, the population aged 80 years or above was 125 million in 2015. It is expected rise to 202 million and 434 million in 2030 and 2050, respectively.

Global Cardiopulmonary Stress Testing Systems Market: Competitive Landscape

  • This report profiles major players in the global cardiopulmonary stress testing systems market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiopulmonary stress testing systems market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global cardiopulmonary stress testing systems market are
    • General Electric
    • Company
    • Koninklijke Philips N.V.
    • CareFusion Corporation (BD)
    • Spacelabs Healthcare (OSI Systems, Inc.)
    • COSMED srl
    • MGC Diagnostic Corporation
    • Nihon Kohden Corporation
    • Schiller AG
    • SunTech Medical, Inc.
    • Welch Allyn among others

Global Cardiopulmonary Stress Testing Systems Market: Key Developments

Key players in the global cardiopulmonary stress testing systems market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global cardiopulmonary stress testing systems market. Major acquisitions and research & development advances adopted by players operating in the global cardiopulmonary stress testing systems market are:

  • In January 2019, the company gained FDA clearance for Masimo MightySat Rx, a Fingertip Pulse Oximeter with SET for home use.
  • In May 2015, Welch Allyn, Inc. opened new development and technology center in Beaverton, Oregon (U.S.). The facility is 34,000-square foot and is designed to accelerate design, development, and education related to medical diagnostic equipment.
  • In October 2014, Becton, Dickinson and Company (BD) acquired CareFusion Corporation for US$ 12.2 billion. As per the terms of the agreement, the two companies will work together for the development of sophisticated patient care and cost-effective products utilized in hospitals, pharmacies, and care centers. The agreement will enable the companies to boost efficiency in terms of patient care, reduction in medication administration errors, and improvement in patient and health care safety.

The report on the global cardiopulmonary stress testing systems market discussed individual strategies, followed by company profiles of manufacturers of cardiopulmonary stress testing systems. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiopulmonary stress testing systems market.

Frequently Asked Questions

What is the total market worth of cardiopulmonary stress testing systems market?

Cardiopulmonary stress testing systems market to reach US$ 7.6 Bn by 2027

What is the anticipated CAGR of the cardiopulmonary stress testing systems market in the forecast period?

Cardiopulmonary stress testing systems market is anticipated to expand at a CAGR of 5.9% from 2019 to 2027

What are the key driving factors for the growth of the cardiopulmonary stress testing systems market?

Cardiopulmonary stress testing systems market is driven by increase prevalence of coronary artery disease

Which region is expected to project the highest market share in the global cardiopulmonary stress testing systems market?

North America accounted for a major share of the global cardiopulmonary stress testing systems market and the trend is anticipated to continue during the forecast period.

Who are the key players in the global cardiopulmonary stress testing systems market?

Key players in the global cardiopulmonary stress testing systems market include General Electric Company, Koninklijke Philips N.V., CareFusion Corporation (BD), Spacelabs Healthcare (OSI Systems, Inc.), COSMED srl

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, 2017-2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Number of Cardiac Stress Test Procedures Performed from MPI SPECT Test in U.S. and Europe

    5.2. Pricing Analysis

    5.3. Epidemiology of Coronary Artery Disease, by Key Countries

6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Product Type, 2017-2027

        6.2.1. CPET Systems

            6.2.1.1. Stationary

            6.2.1.2. Portable

        6.2.2. Stress ECG

        6.2.3. Pulse Oximeters

        6.2.4. Stress BP Monitors

        6.2.5. Single-Photon Emission Computed Tomography (SPECT)

    6.3. Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type

7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Region

    7.1. Key Findings

    7.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Region

        7.2.1. North America

        7.2.2. Europe

        7.2.3. Asia Pacific

        7.2.4. Latin America

        7.2.5. Middle East & Africa

    7.3. North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Region

8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        8.2.1. CPET Systems

            8.2.1.1. Stationary

            8.2.1.2. Portable

        8.2.2. Stress ECG

        8.2.3. Pulse Oximeters

        8.2.4. Stress BP Monitors

        8.2.5. Single-Photon Emission Computed Tomography (SPECT)

    8.3. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017-2027

        8.3.1. U.S.

        8.3.2. Canada

    8.4. North America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        8.4.1. By Product Type

        8.4.2. By Country

9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        9.2.1. CPET Systems

            9.2.1.1. Stationary

            9.2.1.2. Portable

        9.2.2. Stress ECG

        9.2.3. Pulse Oximeters

        9.2.4. Stress BP Monitors

        9.2.5. Single-Photon Emission Computed Tomography (SPECT)

    9.3. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Spain

        9.3.5. Italy

        9.3.6. Rest of Europe

    9.4. Europe Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        9.4.1. By Product Type

        9.4.2. By Country/Sub-region

10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        10.2.1. CPET Systems

            10.2.1.1. Stationary

            10.2.1.2. Portable

        10.2.2. Stress ECG

        10.2.3. Pulse Oximeters

        10.2.4. Stress BP Monitors

        10.2.5. Single-Photon Emission Computed Tomography (SPECT)

    10.3. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        10.4.1. By Product Type

        10.4.2. By Country/Sub-region

11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        11.2.1. CPET Systems

            11.2.1.1. Stationary

            11.2.1.2. Portable

        11.2.2. Stress ECG

        11.2.3. Pulse Oximeters

        11.2.4. Stress BP Monitors

        11.2.5. Single-Photon Emission Computed Tomography (SPECT)

    11.3. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America Latin America

    11.4. Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        11.4.1. By Product Type

        11.4.2. By Country/Sub-region

12. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

        12.2.1. CPET Systems

            12.2.1.1. Stationary

            12.2.1.2. Portable

        12.2.2. Stress ECG

        12.2.3. Pulse Oximeters

        12.2.4. Stress BP Monitors

        12.2.5. Single-Photon Emission Computed Tomography (SPECT)

    12.3. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        12.4.1. By Product Type

        12.4.2. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player - Competition Matrix (by Tier and Size of companies)

    13.2. Market Share / Position Analysis, by Company, 2018

    13.3. Company Profiles

        13.3.1. General Electric Company

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.1.2. Financial Overview

            13.3.1.3. Strategic Overview

            13.3.1.4. SWOT Analysis

        13.3.2. Koninklijke Philips N.V.

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.2.2. Financial Overview

            13.3.2.3. Strategic Overview

            13.3.2.4. SWOT Analysis

        13.3.3. CareFusion Corporation (BD)

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.3.2. Financial Overview

            13.3.3.3. Strategic Overview

            13.3.3.4. SWOT Analysis

        13.3.4. Spacelabs Healthcare (OSI Systems, Inc.)

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.4.2. Financial Overview

            13.3.4.3. Strategic Overview

            13.3.4.4. SWOT Analysis

        13.3.5. COSMED srl

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.5.2. Financial Overview

            13.3.5.3. Strategic Overview

            13.3.5.4. SWOT Analysis

        13.3.6. MGC Diagnostic Corporation

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.6.2. Financial Overview

            13.3.6.3. Strategic Overview

            13.3.6.4. SWOT Analysis

        13.3.7. Nihon Kohden Corporation

            13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.7.2. Financial Overview

            13.3.7.3. Strategic Overview

            13.3.7.4. SWOT Analysis

        13.3.8. Schiller AG

            13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.8.2. Financial Overview

            13.3.8.3. Strategic Overview

            13.3.8.4. SWOT Analysis

        13.3.9. SunTech Medical, Inc.

            13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.9.2. Financial Overview

            13.3.9.3. Strategic Overview

            13.3.9.4. SWOT Analysis

        13.3.10. Welch Allyn

            13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.10.2. Financial Overview

            13.3.10.3. Strategic Overview

            13.3.10.4. SWOT Analysis

List of Tables

Table 01: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 02: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Region, 2017-2027

Table 03: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017-2027

Table 04: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 05: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 06: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 07: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 08: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 09: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 10: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 11: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Passive Approximators, 2017-2027

Table 12: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 13: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017-2027

List of Figure

Figure 01: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) and Forecast, 2019-2027

Figure 02: Global Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type Type, 2018

Figure 03: Global Cardiopulmonary Stress Testing Systems Market Value Share, by Region, 2018

Figure 04: Global Cardiopulmonary Stress Testing Systems Market Value Share Analysis, by Product Type Type, 2018 and 2027

Figure 05: Global Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis, by Product Type Type, 2018-2027

Figure 06: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by CPET Systems, 2017-2027

Figure 07: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Stress ECG, 2017-2027

Figure 08: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Pulse Oximeters, 2017-2027

Figure 09: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Stress BP Monitors, 2017-2027

Figure 10: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Single-Photon Emission Computed Tomography (SPECT), 2017-2027

Figure 11: Global Cardiopulmonary Stress Testing Systems Market Value Share Analysis, by Region, 2018 and 2027

Figure 12: Global Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis, by Region, 2018-2027

Figure 13: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 14: North America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country, 2018 and 2027

Figure 15: North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country, 2019-2027

Figure 16: North America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 17: North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019-2027

Figure 18: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 19: Europe Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 20: Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 21: Europe Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 22: Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019-2027

Figure 23: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 24: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 25: Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 26: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 27: Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019-2027

Figure 28: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 29: Latin America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 30: Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 31: Latin America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 32: Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019-2027

Figure 33: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 34: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 35: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 36: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 37: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019-2027

Figure 38: General Electric Company Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 39: General Electric Company Breakdown of Net Sales (%), by Business Segment, 2018

Figure 40: General Electric Company Breakdown of Net Sales (%), by Region, 2018

Figure 41: General Electric Company R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 42: Koninklijke Philips N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 43: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 44: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region, 2018

Figure 45: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 46: CareFusion Corporation (BD) Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 47: CareFusion Corporation (BD) Breakdown of Net Sales (%), by Business Segment, 2018

Figure 48: CareFusion Corporation (BD) Breakdown of Net Sales (%), by Region, 2018

Figure 49: CareFusion Corporation (BD) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 50: Spacelabs Healthcare (OSI Systems, Inc.) Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 51: Spacelabs Healthcare (OSI Systems, Inc.) Breakdown of Net Sales (%), by Business Segment, 2018

Figure 52: Spacelabs Healthcare (OSI Systems, Inc.) Breakdown of Net Sales (%), by Region, 2018

Figure 53: Spacelabs Healthcare (OSI Systems, Inc.) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 54: COSMED srl Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 55: COSMED srl Breakdown of Net Sales (%), by Business Segment, 2018

Figure 56: COSMED srl Breakdown of Net Sales (%), by Region, 2018

Figure 57: COSMED srl R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 58: MGC Diagnostic Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 59: MGC Diagnostic Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Figure 60: MGC Diagnostic Corporation Breakdown of Net Sales (%), by Region, 2018

Figure 61: MGC Diagnostic Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 62: Nihon Kohden Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 63: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Figure 64: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region, 2018

Figure 65: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 66: Schiller AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 67: Schiller AG Breakdown of Net Sales (%), by Business Segment, 2018

Figure 68: Schiller AG Breakdown of Net Sales (%), by Region, 2018

Figure 69: Schiller AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 70: SunTech Medical, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 71: SunTech Medical, Inc. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 72: SunTech Medical, Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 73: SunTech Medical, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 74: Welch Allyn Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 75: Welch Allyn Breakdown of Net Sales (%), by Business Segment, 2018

Figure 76: Welch Allyn Breakdown of Net Sales (%), by Region, 2018

Figure 77: Welch Allyn R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Cardiopulmonary Stress Testing Systems Market Insights, 2019-2027

Schedule a Call